Dr. Max Konig MD

Maximilian F. Konig is an Assistant Professor of Medicine in the Division of Rheumatology and the Ludwig Center for Cancer Genetics and Therapeutics at the Johns Hopkins University School of Medicine. He received his medical degree from Charité – Universitätsmedizin Berlin and completed his residency training in Internal Medicine in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. Dr. Konig completed fellowship training in Clinical and Molecular Rheumatology and Advanced Rheumatology at Johns Hopkins Hospital. In addition to his clinical training, he completed postdoctoral research fellowships in rheumatology and oncology, before joining the faculty at Johns Hopkins where he serves as Director of the Cellular Therapy Program (Autoimmunity). Dr. Konig’s research interests include immuno-engineering and elucidating mechanisms underlying the initiation and progression of autoimmune diseases. His lab develops precision cellular and antibody-based immunotherapies for the treatment of rheumatic diseases, aiming to selectively eliminate autoreactive immune cells while preserving protective immune responses. His group employs similar engineering approaches to develop more potent cellular therapies for hard-to-treat cancers.